
CJC-1295 No DAC / Ipamorelin Blend
- Growth-hormone research
- GH/IGF-1 pathway research
- Recovery research
- Body-composition research
Combined research peptide blend for protocols requiring both ghrelin mimetic and GHRH analog components in one vial.
Lab results
Certificate of analysis for CJC-1295 No DAC / Ipamorelin Blend.
View certificate (opens in new tab)Available sizes
Quantity
3,930 EGP
Verification
Confirm your research affiliation before payment options are shown.
How to pay
Complete verification above to unlock InstaPay and CliQ payment links.
Product specifications
| Form | Lyophilized peptide powder |
|---|---|
| Purity | ≥ 98% (third-party verified) |
| Storage | Store sealed, cool and dry; research use only |
| Intended use | CJC-1295 / Ipamorelin blend — in vitro / laboratory research only |
| 5mg/5mg vial | Lyophilized peptide powder supplied in 3ml vial. |
| 10mg/10mg vial | Lyophilized peptide powder supplied in 3ml vial. |
What is CJC-1295 No DAC / Ipamorelin Blend?
This blend pairs a GHRH analog with a selective ghrelin receptor agonist peptide for research exploring growth hormone secretagogue pathways.
Mechanism of action (research context)
Non-clinical studies investigate synergistic secretagogue signaling. Combined effects are model-specific and not intended for therapeutic translation.
Chemical structure
Each component is synthesized and verified independently before blending; batch records document both peptide identities.
Related peptides

Retatrutide
- Weight-management research
- Appetite-regulation research
- Metabolic research
From 3,300 EGP

GHK-Cu
- Skin-repair research
- Collagen support
- Skin elasticity support
- Fine-line support
- Hair-follicle research
- Tissue-repair research
From 2,360 EGP

Semaglutide
- Weight management
- Appetite control
- Blood-sugar support
- Cardiovascular-risk reduction in certain approved populations
From 3,410 EGP

Tirzepatide
- Weight management
- Appetite control
- Blood-sugar support
- Metabolic-health support
From 3,930 EGP
